Cumberland Pharmaceuticals CPIX
NASDAQ CPIX
$8.29 +0.33 (+4.15%)
As of: Oct 21, 2026 · 12:23 PM EDT

Cumberland Pharmaceuticals (CPIX) Research & Development (2010 - 2026)

Updated

Cumberland Pharmaceuticals' Research & Development came in at $772,162 for Q2 2026, down 7.8% from $837,401 a year earlier and down 47.1% from the prior quarter.

Analysis

Cumberland Pharmaceuticals (CPIX) Research & Development (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Cumberland Pharmaceuticals reported Research & Development of $5.03 million, up 6.4% year-over-year; for FY2025, it was $5.57 million, up 15.6% from FY2024.

  • Research & Development carries a five-year compound annual growth rate of -0.7% (FY2020 to FY2025).
  • Going back by year, Research & Development was $4.82 million in FY2024 (-17.4%), $5.83 million in FY2023 (-12.8%), $6.69 million in FY2022 (+17.7%) and $5.68 million in FY2021 (-1.5%).
  • The Q2 2026 figure represents the lowest quarterly Research & Development since Q3 2016.
  • Year-over-year, Research & Development increased in four of the last eight quarters, with an average decline of 2.3%.
  • The fastest year-over-year change in Research & Development over five years came in Q1 2022 (growth of 38.8%), and the weakest in Q2 2023 (a decline of 37.2%).
  • Business Quant data shows CPIX's Research & Development at $1.46 million (Q1 2026), $1.55 million (Q4 2025) and $1.25 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,132.21 Bn 1,100.80 Bn 19.71 Bn 3.82 Bn
2 Johnson & Johnson 616.27 Bn 534.80 Bn 17.26 Bn 3.65 Bn
3 AbbVie 500.10 Bn 473.21 Bn 12.70 Bn 2.34 Bn
4 Merck 366.86 Bn 321.23 Bn 12.21 Bn 9.74 Bn
5 Novartis Ag 297.92 Bn 261.91 Bn 11.24 Bn 2.85 Bn
6 Astrazeneca 261.53 Bn 235.22 Bn 12.86 Bn 4.05 Bn
7 Amgen 234.99 Bn 190.39 Bn 7.24 Bn 1.87 Bn
8 Gilead Sciences 190.14 Bn 164.34 Bn 6.22 Bn 1.76 Bn
9 Pfizer 169.63 Bn 116.28 Bn 10.94 Bn 2.81 Bn
10 Cumberland Pharmaceuticals 124.20 Mn 82.69 Mn - 772,162.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 772,162.00
Mar 31, 2026 1.46 Mn
Dec 31, 2025 1.55 Mn
Sep 30, 2025 1.25 Mn
Jun 30, 2025 837,401.00
Mar 31, 2025 1.30 Mn
Dec 31, 2024 1.29 Mn
Sep 30, 2024 1.31 Mn
Jun 30, 2024 1.06 Mn
Mar 31, 2024 1.16 Mn
Dec 31, 2023 1.26 Mn
Sep 30, 2023 1.92 Mn
Jun 30, 2023 1.15 Mn
Mar 31, 2023 1.50 Mn
Dec 31, 2022 1.41 Mn
Sep 30, 2022 1.71 Mn
Jun 30, 2022 1.82 Mn
Mar 31, 2022 1.75 Mn
Dec 31, 2021 1.61 Mn
Sep 30, 2021 1.45 Mn
API Access

Cumberland Pharmaceuticals Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=CPIX&period=max&api_key=YOUR_API_KEY